Cipher Pharmaceuticals https://cipher.investorroom.com/ Cipher Pharmaceuticals Announces A-101 40% Topical Solution Accepted for Review by Health Canada https://cipher.investorroom.com/2018-12-18-Cipher-Pharmaceuticals-Announces-A-101-40-Topical-Solution-Accepted-for-Review-by-Health-Canada Tue, 18 Dec 2018 07:00:00 -0500 https://cipher.investorroom.com/2018-12-18-Cipher-Pharmaceuticals-Announces-A-101-40-Topical-Solution-Accepted-for-Review-by-Health-Canada Cipher Pharmaceuticals Announces PLECANATIDE Accepted for Review by Health Canada https://cipher.investorroom.com/2018-12-17-Cipher-Pharmaceuticals-Announces-PLECANATIDE-Accepted-for-Review-by-Health-Canada Mon, 17 Dec 2018 07:00:00 -0500 https://cipher.investorroom.com/2018-12-17-Cipher-Pharmaceuticals-Announces-PLECANATIDE-Accepted-for-Review-by-Health-Canada Cipher Pharmaceuticals to Host Investor Webcast on December 11TH, 2018 https://cipher.investorroom.com/2018-12-05-Cipher-Pharmaceuticals-to-Host-Investor-Webcast-on-December-11TH-2018 Wed, 05 Dec 2018 11:00:00 -0500 https://cipher.investorroom.com/2018-12-05-Cipher-Pharmaceuticals-to-Host-Investor-Webcast-on-December-11TH-2018 Cipher Pharmaceuticals adds new Vice President, Canadian Commercial Operations https://cipher.investorroom.com/2018-12-04-Cipher-Pharmaceuticals-adds-new-Vice-President-Canadian-Commercial-Operations Tue, 04 Dec 2018 07:00:00 -0500 https://cipher.investorroom.com/2018-12-04-Cipher-Pharmaceuticals-adds-new-Vice-President-Canadian-Commercial-Operations Cipher Pharmaceuticals Reports Q3 2018 Results https://cipher.investorroom.com/2018-11-07-Cipher-Pharmaceuticals-Reports-Q3-2018-Results Wed, 07 Nov 2018 07:00:00 -0500 https://cipher.investorroom.com/2018-11-07-Cipher-Pharmaceuticals-Reports-Q3-2018-Results